Michael Blalock - 14 Jun 2024 Form 4 Insider Report for Sharecare, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Jun 2024, 21:32:20 UTC
Prior SEC filing
17 May 2024
Next SEC filing
15 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christie J. Miller, Attorney-in-Fact for Reporting Person

Key filing fact

Michael Blalock filed Form 4 for Sharecare, Inc. on 18 Jun 2024.

Key facts

  • This page summarizes Michael Blalock's Form 4 filing for Sharecare, Inc..
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 18 Jun 2024, 21:32.

Change

  • Previous filing in this sequence was filed on 17 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SHCR transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+550,000
Change %
Price
$0.000000
Shares after
550,000
Date
14 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
550,000
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.0001 per share ("Common Stock"), of Sharecare, Inc. (the "Company"), or as determined by the administrator, cash equal to the fair market value of one share of Common Stock on the settlement date.

Footnote F2

Represents annual equity grants to employees. One-twelfth (1/12) of the RSUs will vest on the grant date (with settlement within thirty (30) days thereof). Thereafter one-twelfth (1/12) of the RSUs will vest quarterly on June 30, September 30, and December 31 of each of 2024, 2025, and 2026 and March 31 of 2025 and 2026, provided that Reporting Person is still employed by the Company or an affiliate thereof through the applicable vesting dates.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .